The Wall Street Journal runs an article profiling multimillionaire and melanoma patient Jay Tenenbaum and the company he founded, CollabRx, to get patients involved in helping develop therapeutics faster and for less money than the process currently takes. The projects that CollabRx takes on are called "virtual biotechs," according to the story, "because they aim to replicate many of the steps typically taken as part of a pharmaceutical or biotech company's search for a new drug."

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.